CN Stock MarketDetailed Quotes

300122 Chongqing Zhifei Biological Products

Watchlist
  • 33.38
  • +5.56+19.99%
Market Closed Sep 30 15:00 CST
79.90BMarket Cap13.22P/E (TTM)

Chongqing Zhifei Biological Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
65.72%5.59B
6.30%2.97B
141.81%6.34B
8.54%2.9B
-0.23%3.37B
42.11%2.8B
-39.13%2.62B
-37.79%2.67B
-33.68%3.38B
47.17%1.97B
Notes receivable and accounts receivable
-1.56%25.47B
26.22%30.03B
31.26%27.06B
51.46%28.62B
44.43%25.88B
41.78%23.79B
60.20%20.61B
79.69%18.9B
104.63%17.92B
108.16%16.78B
-Accounts receivable
-1.56%25.47B
26.22%30.03B
31.26%27.06B
51.46%28.62B
44.43%25.88B
41.78%23.79B
60.20%20.61B
79.69%18.9B
104.63%17.92B
108.16%16.78B
Other receivables (including interest and dividends)
-95.36%8.02M
-10.44%13.24M
-7.11%7.8M
8.64%11.55M
1,486.51%172.69M
59.92%14.78M
22.10%8.39M
-39.29%10.63M
-21.64%10.89M
-18.07%9.24M
-Other receivable
-95.36%8.02M
----
-7.11%7.8M
----
1,486.51%172.69M
----
22.10%8.39M
----
-21.64%10.89M
----
Advance payment
-50.41%55.74M
-45.39%67.95M
-27.89%74.37M
-5.17%121.94M
-24.26%112.39M
-34.41%124.41M
-44.44%103.14M
-28.59%128.59M
96.91%148.38M
174.82%189.67M
Inventories
37.61%15.65B
31.08%12.61B
12.04%8.99B
29.02%10.41B
59.05%11.37B
45.18%9.62B
8.60%8.02B
20.09%8.07B
47.83%7.15B
89.18%6.62B
Assets held for sale
--37M
--37M
--37M
----
----
----
----
----
----
----
Non-current assets due within one year
----
----
----
----
--18.97K
----
----
----
----
----
Other current assets
-99.99%16.8
-92.79%5.1M
-78.56%9.73M
-99.80%166.47K
-98.07%155.31K
5,403.18%70.76M
7,623.11%45.39M
354.98%81.91M
323.71%8.05M
-65.41%1.29M
Total current assets
14.43%46.81B
25.58%45.73B
35.34%42.51B
40.88%42.07B
42.96%40.91B
42.39%36.42B
26.90%31.41B
37.31%29.86B
52.37%28.61B
96.96%25.57B
Non Current assets
Other equity investment
3.69%295M
3.69%295M
3.69%295M
14.03%284.5M
19.04%284.5M
19.04%284.5M
19.04%284.5M
4.39%249.5M
6.70%239M
23.20%239M
Investment real estate
-97.73%221.31K
-97.55%243.64K
-97.38%265.97K
-7.60%9.56M
-7.46%9.76M
-7.32%9.95M
-7.19%10.15M
-7.06%10.34M
-6.94%10.54M
-6.82%10.74M
Fixed assets
20.25%3.7B
----
34.70%3.8B
----
34.15%3.08B
----
63.98%2.82B
----
39.09%2.29B
----
Fixed assets liquidation
-50.60%245.63K
----
-22.91%262.59K
----
746.04%497.22K
----
1,235.74%340.63K
----
-8.78%58.77K
----
Constru in process
-20.99%1.37B
----
-29.88%1.29B
----
-0.35%1.73B
----
0.59%1.84B
----
35.00%1.74B
----
Intangible assets
22.82%304.93M
-10.45%311.16M
-9.93%317.68M
-9.79%322.47M
-30.96%248.28M
8.97%347.48M
2.89%352.71M
8.94%357.48M
8.53%359.63M
19.71%318.86M
Development expenditure
30.98%1.11B
42.37%1.04B
42.83%1.01B
37.36%874.63M
47.84%850M
44.70%730.31M
58.31%703.73M
-32.74%636.73M
-37.74%574.93M
17.62%504.7M
Goodwill
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
0.00%19.28M
Long deferred expense
165.11%86.94M
131.54%84.1M
193.96%82.99M
6.77%31.82M
-2.44%32.79M
-2.65%36.32M
-30.32%28.23M
5.07%29.8M
7.06%33.61M
8.36%37.31M
Deferred tax assets
130.16%754.6M
210.39%641.52M
205.89%569.19M
127.92%383.46M
101.73%327.86M
51.30%206.68M
61.33%186.08M
81.69%168.25M
80.56%162.52M
13.96%136.6M
Usufruct assets
1.19%33.5M
-4.60%34.91M
-6.17%37.06M
-7.18%39.62M
-26.97%33.11M
204.65%36.6M
189.35%39.5M
359.93%42.68M
450.71%45.34M
53.39%12.01M
Other non current assets
5.65%353.07M
-21.80%321.31M
-1.32%307.89M
-39.50%321.51M
-43.02%334.21M
-25.40%410.89M
-40.45%312.02M
5.77%531.44M
5.45%586.52M
-7.38%550.76M
Total non current assets
15.53%8.03B
14.80%7.84B
17.11%7.72B
13.14%7.21B
14.61%6.95B
20.66%6.83B
24.50%6.59B
16.16%6.37B
18.16%6.07B
36.55%5.66B
Total assets
14.59%54.85B
23.88%53.57B
32.18%50.23B
36.01%49.27B
38.00%47.86B
38.46%43.24B
26.48%38B
33.05%36.23B
45.03%34.68B
82.34%31.23B
Liabilities
Current liabilities
Short term loan
22.93%3.44B
21.03%4.58B
47.65%2.64B
112.03%3.96B
3.77%2.8B
57.29%3.78B
213.77%1.78B
284.82%1.87B
51.34%2.7B
-35.51%2.4B
Notes payable and accounts payable
7.68%16.34B
25.66%14.18B
34.00%13.14B
26.56%13.17B
64.13%15.17B
46.39%11.28B
6.85%9.81B
18.64%10.4B
55.34%9.24B
123.88%7.71B
-Notes payable
----
----
----
----
----
-68.65%5.42M
-45.30%14.67M
-70.07%15.12M
-98.12%1.4M
-74.75%17.29M
-Accounts payable
7.68%16.34B
25.72%14.18B
34.20%13.14B
26.74%13.17B
64.16%15.17B
46.65%11.28B
7.00%9.79B
19.15%10.39B
57.28%9.24B
127.91%7.69B
Contract liabilities
--5.57M
--5.95M
--11.31M
--7.55M
----
----
----
----
----
----
Advance receipts
3,068.54%28.83M
177.94%35.62M
1,158.83%114.11M
-57.73%2.82M
-98.02%909.88K
-77.73%12.82M
-87.22%9.07M
-95.17%6.67M
-93.06%46.03M
5,960.58%57.54M
Salaries payable
11.28%50.93M
1.67%37.14M
18.90%216.65M
14.30%55.77M
-3.75%45.77M
-46.74%36.53M
21.52%182.21M
-88.16%48.8M
-89.14%47.55M
220.48%68.58M
Taxs payable
-56.53%497.1M
-0.27%1.01B
34.82%1.55B
32.65%1.16B
62.80%1.14B
9.33%1.01B
-31.80%1.15B
-15.51%874.25M
-27.30%702.37M
135.90%926.78M
Other payable (including interest and dividends)
598.83%2.23B
37.24%315.66M
28.98%366.58M
30.90%277.8M
-72.76%318.93M
20.43%230M
33.73%284.22M
20.68%212.22M
900.37%1.17B
88.31%190.99M
-Interest payable
----
----
----
146.60%3.03M
-35.31%2.17M
9.54%2.81M
191.22%1.42M
460.67%1.23M
-8.48%3.36M
-66.49%2.57M
-Dividend payable
--1.92B
----
----
----
----
----
----
----
--960M
----
-Other payable
-0.96%313.72M
----
29.63%366.58M
----
52.71%316.75M
----
33.37%282.79M
----
82.97%207.42M
----
Non current liabilities due within one year
778.97%61.25M
576.23%53.37M
375.39%46.61M
83.75%10.3M
26.17%6.97M
2,498.55%7.89M
3,846.26%9.81M
--5.6M
--5.52M
--303.72K
Total current liabilities
16.23%22.65B
23.52%20.21B
36.71%18.09B
38.91%18.64B
40.06%19.49B
44.11%16.36B
11.45%13.23B
21.82%13.42B
40.08%13.92B
47.53%11.35B
Current liabilities
Long term loan
13.68%379.08M
39.97%385.01M
55.75%328.08M
127.97%338.9M
--333.46M
--275.06M
-10.90%210.64M
85.82%148.66M
----
----
Deferred tax liabilities
-9.08%53.75M
-4.94%57.76M
-4.62%57.96M
-14.03%61.27M
-9.77%59.11M
16.19%60.76M
25.71%60.77M
139.73%71.27M
120.35%65.52M
75.38%52.3M
Long term deferred income
-16.33%215.36M
-8.11%227.52M
-4.22%228.27M
-4.72%238.94M
9.01%257.39M
5.75%247.58M
7.26%238.34M
2.88%250.77M
15.99%236.12M
14.22%234.13M
Lease liabilities
-23.59%19.08M
-16.29%22.76M
-8.85%25.31M
-20.50%27.68M
-34.35%24.97M
148.22%27.19M
126.83%27.76M
300.27%34.82M
426.76%38.03M
65.30%10.96M
Total non current liabilities
-1.13%667.27M
13.50%693.05M
19.00%639.62M
31.90%666.79M
98.70%674.93M
105.33%610.6M
3.53%537.52M
39.57%505.52M
41.22%339.67M
21.53%297.38M
Total liabilities
15.65%23.32B
23.16%20.91B
36.02%18.73B
38.66%19.31B
41.46%20.16B
45.68%16.97B
11.12%13.77B
22.38%13.92B
40.11%14.25B
46.73%11.65B
Shareholders equity
Paid-in capital
-0.26%2.39B
50.00%2.4B
50.00%2.4B
50.00%2.4B
50.00%2.4B
0.00%1.6B
0.00%1.6B
0.00%1.6B
0.00%1.6B
0.00%1.6B
Capital reserve funds
----
-76.94%47.96M
-76.94%47.96M
-76.94%47.96M
-76.94%47.96M
0.00%207.96M
0.00%207.96M
0.00%207.96M
0.00%207.96M
0.00%207.96M
Surplus reserve funds
19.27%954.14M
50.00%1.2B
50.00%1.2B
0.00%800M
0.00%800M
0.00%800M
0.00%800M
1.95%800M
1.95%800M
1.95%800M
Retained profit
15.25%28.18B
23.90%29.32B
28.80%27.86B
35.65%26.72B
37.21%24.45B
39.41%23.66B
43.72%21.63B
48.54%19.7B
59.85%17.82B
157.38%16.97B
Less:Treasury stock
----
--300.03M
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
13.83%31.53B
24.35%32.66B
30.00%31.51B
34.35%29.97B
35.59%27.7B
34.16%26.27B
37.26%24.24B
40.70%22.3B
48.67%20.43B
113.13%19.58B
Total shareholder equity
13.83%31.53B
24.35%32.66B
30.00%31.51B
34.35%29.97B
35.59%27.7B
34.16%26.27B
37.26%24.24B
40.70%22.3B
48.67%20.43B
113.13%19.58B
Total liabilityies and equity
14.59%54.85B
23.88%53.57B
32.18%50.23B
36.01%49.27B
38.00%47.86B
38.46%43.24B
26.48%38B
33.05%36.23B
45.03%34.68B
82.34%31.23B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 65.72%5.59B6.30%2.97B141.81%6.34B8.54%2.9B-0.23%3.37B42.11%2.8B-39.13%2.62B-37.79%2.67B-33.68%3.38B47.17%1.97B
Notes receivable and accounts receivable -1.56%25.47B26.22%30.03B31.26%27.06B51.46%28.62B44.43%25.88B41.78%23.79B60.20%20.61B79.69%18.9B104.63%17.92B108.16%16.78B
-Accounts receivable -1.56%25.47B26.22%30.03B31.26%27.06B51.46%28.62B44.43%25.88B41.78%23.79B60.20%20.61B79.69%18.9B104.63%17.92B108.16%16.78B
Other receivables (including interest and dividends) -95.36%8.02M-10.44%13.24M-7.11%7.8M8.64%11.55M1,486.51%172.69M59.92%14.78M22.10%8.39M-39.29%10.63M-21.64%10.89M-18.07%9.24M
-Other receivable -95.36%8.02M-----7.11%7.8M----1,486.51%172.69M----22.10%8.39M-----21.64%10.89M----
Advance payment -50.41%55.74M-45.39%67.95M-27.89%74.37M-5.17%121.94M-24.26%112.39M-34.41%124.41M-44.44%103.14M-28.59%128.59M96.91%148.38M174.82%189.67M
Inventories 37.61%15.65B31.08%12.61B12.04%8.99B29.02%10.41B59.05%11.37B45.18%9.62B8.60%8.02B20.09%8.07B47.83%7.15B89.18%6.62B
Assets held for sale --37M--37M--37M----------------------------
Non-current assets due within one year ------------------18.97K--------------------
Other current assets -99.99%16.8-92.79%5.1M-78.56%9.73M-99.80%166.47K-98.07%155.31K5,403.18%70.76M7,623.11%45.39M354.98%81.91M323.71%8.05M-65.41%1.29M
Total current assets 14.43%46.81B25.58%45.73B35.34%42.51B40.88%42.07B42.96%40.91B42.39%36.42B26.90%31.41B37.31%29.86B52.37%28.61B96.96%25.57B
Non Current assets
Other equity investment 3.69%295M3.69%295M3.69%295M14.03%284.5M19.04%284.5M19.04%284.5M19.04%284.5M4.39%249.5M6.70%239M23.20%239M
Investment real estate -97.73%221.31K-97.55%243.64K-97.38%265.97K-7.60%9.56M-7.46%9.76M-7.32%9.95M-7.19%10.15M-7.06%10.34M-6.94%10.54M-6.82%10.74M
Fixed assets 20.25%3.7B----34.70%3.8B----34.15%3.08B----63.98%2.82B----39.09%2.29B----
Fixed assets liquidation -50.60%245.63K-----22.91%262.59K----746.04%497.22K----1,235.74%340.63K-----8.78%58.77K----
Constru in process -20.99%1.37B-----29.88%1.29B-----0.35%1.73B----0.59%1.84B----35.00%1.74B----
Intangible assets 22.82%304.93M-10.45%311.16M-9.93%317.68M-9.79%322.47M-30.96%248.28M8.97%347.48M2.89%352.71M8.94%357.48M8.53%359.63M19.71%318.86M
Development expenditure 30.98%1.11B42.37%1.04B42.83%1.01B37.36%874.63M47.84%850M44.70%730.31M58.31%703.73M-32.74%636.73M-37.74%574.93M17.62%504.7M
Goodwill 0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M0.00%19.28M
Long deferred expense 165.11%86.94M131.54%84.1M193.96%82.99M6.77%31.82M-2.44%32.79M-2.65%36.32M-30.32%28.23M5.07%29.8M7.06%33.61M8.36%37.31M
Deferred tax assets 130.16%754.6M210.39%641.52M205.89%569.19M127.92%383.46M101.73%327.86M51.30%206.68M61.33%186.08M81.69%168.25M80.56%162.52M13.96%136.6M
Usufruct assets 1.19%33.5M-4.60%34.91M-6.17%37.06M-7.18%39.62M-26.97%33.11M204.65%36.6M189.35%39.5M359.93%42.68M450.71%45.34M53.39%12.01M
Other non current assets 5.65%353.07M-21.80%321.31M-1.32%307.89M-39.50%321.51M-43.02%334.21M-25.40%410.89M-40.45%312.02M5.77%531.44M5.45%586.52M-7.38%550.76M
Total non current assets 15.53%8.03B14.80%7.84B17.11%7.72B13.14%7.21B14.61%6.95B20.66%6.83B24.50%6.59B16.16%6.37B18.16%6.07B36.55%5.66B
Total assets 14.59%54.85B23.88%53.57B32.18%50.23B36.01%49.27B38.00%47.86B38.46%43.24B26.48%38B33.05%36.23B45.03%34.68B82.34%31.23B
Liabilities
Current liabilities
Short term loan 22.93%3.44B21.03%4.58B47.65%2.64B112.03%3.96B3.77%2.8B57.29%3.78B213.77%1.78B284.82%1.87B51.34%2.7B-35.51%2.4B
Notes payable and accounts payable 7.68%16.34B25.66%14.18B34.00%13.14B26.56%13.17B64.13%15.17B46.39%11.28B6.85%9.81B18.64%10.4B55.34%9.24B123.88%7.71B
-Notes payable ---------------------68.65%5.42M-45.30%14.67M-70.07%15.12M-98.12%1.4M-74.75%17.29M
-Accounts payable 7.68%16.34B25.72%14.18B34.20%13.14B26.74%13.17B64.16%15.17B46.65%11.28B7.00%9.79B19.15%10.39B57.28%9.24B127.91%7.69B
Contract liabilities --5.57M--5.95M--11.31M--7.55M------------------------
Advance receipts 3,068.54%28.83M177.94%35.62M1,158.83%114.11M-57.73%2.82M-98.02%909.88K-77.73%12.82M-87.22%9.07M-95.17%6.67M-93.06%46.03M5,960.58%57.54M
Salaries payable 11.28%50.93M1.67%37.14M18.90%216.65M14.30%55.77M-3.75%45.77M-46.74%36.53M21.52%182.21M-88.16%48.8M-89.14%47.55M220.48%68.58M
Taxs payable -56.53%497.1M-0.27%1.01B34.82%1.55B32.65%1.16B62.80%1.14B9.33%1.01B-31.80%1.15B-15.51%874.25M-27.30%702.37M135.90%926.78M
Other payable (including interest and dividends) 598.83%2.23B37.24%315.66M28.98%366.58M30.90%277.8M-72.76%318.93M20.43%230M33.73%284.22M20.68%212.22M900.37%1.17B88.31%190.99M
-Interest payable ------------146.60%3.03M-35.31%2.17M9.54%2.81M191.22%1.42M460.67%1.23M-8.48%3.36M-66.49%2.57M
-Dividend payable --1.92B------------------------------960M----
-Other payable -0.96%313.72M----29.63%366.58M----52.71%316.75M----33.37%282.79M----82.97%207.42M----
Non current liabilities due within one year 778.97%61.25M576.23%53.37M375.39%46.61M83.75%10.3M26.17%6.97M2,498.55%7.89M3,846.26%9.81M--5.6M--5.52M--303.72K
Total current liabilities 16.23%22.65B23.52%20.21B36.71%18.09B38.91%18.64B40.06%19.49B44.11%16.36B11.45%13.23B21.82%13.42B40.08%13.92B47.53%11.35B
Current liabilities
Long term loan 13.68%379.08M39.97%385.01M55.75%328.08M127.97%338.9M--333.46M--275.06M-10.90%210.64M85.82%148.66M--------
Deferred tax liabilities -9.08%53.75M-4.94%57.76M-4.62%57.96M-14.03%61.27M-9.77%59.11M16.19%60.76M25.71%60.77M139.73%71.27M120.35%65.52M75.38%52.3M
Long term deferred income -16.33%215.36M-8.11%227.52M-4.22%228.27M-4.72%238.94M9.01%257.39M5.75%247.58M7.26%238.34M2.88%250.77M15.99%236.12M14.22%234.13M
Lease liabilities -23.59%19.08M-16.29%22.76M-8.85%25.31M-20.50%27.68M-34.35%24.97M148.22%27.19M126.83%27.76M300.27%34.82M426.76%38.03M65.30%10.96M
Total non current liabilities -1.13%667.27M13.50%693.05M19.00%639.62M31.90%666.79M98.70%674.93M105.33%610.6M3.53%537.52M39.57%505.52M41.22%339.67M21.53%297.38M
Total liabilities 15.65%23.32B23.16%20.91B36.02%18.73B38.66%19.31B41.46%20.16B45.68%16.97B11.12%13.77B22.38%13.92B40.11%14.25B46.73%11.65B
Shareholders equity
Paid-in capital -0.26%2.39B50.00%2.4B50.00%2.4B50.00%2.4B50.00%2.4B0.00%1.6B0.00%1.6B0.00%1.6B0.00%1.6B0.00%1.6B
Capital reserve funds -----76.94%47.96M-76.94%47.96M-76.94%47.96M-76.94%47.96M0.00%207.96M0.00%207.96M0.00%207.96M0.00%207.96M0.00%207.96M
Surplus reserve funds 19.27%954.14M50.00%1.2B50.00%1.2B0.00%800M0.00%800M0.00%800M0.00%800M1.95%800M1.95%800M1.95%800M
Retained profit 15.25%28.18B23.90%29.32B28.80%27.86B35.65%26.72B37.21%24.45B39.41%23.66B43.72%21.63B48.54%19.7B59.85%17.82B157.38%16.97B
Less:Treasury stock ------300.03M--------------------------------
Shareholders equity without minority interests 13.83%31.53B24.35%32.66B30.00%31.51B34.35%29.97B35.59%27.7B34.16%26.27B37.26%24.24B40.70%22.3B48.67%20.43B113.13%19.58B
Total shareholder equity 13.83%31.53B24.35%32.66B30.00%31.51B34.35%29.97B35.59%27.7B34.16%26.27B37.26%24.24B40.70%22.3B48.67%20.43B113.13%19.58B
Total liabilityies and equity 14.59%54.85B23.88%53.57B32.18%50.23B36.01%49.27B38.00%47.86B38.46%43.24B26.48%38B33.05%36.23B45.03%34.68B82.34%31.23B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data